Nuformix PLC (NFX)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.25p

Buy

0.28p

arrow-up0.055p (+26.19%)

Prices updated at 12 Dec 2025, 16:30 GMT

Prices minimum 15 mins delay

Prices in GBX

Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	0.29p - 0.20p
	0.56p - 0.01p
	-
	5.59m
	-
	2,000,000
	75,998,075
	6.92
	53,689,259.41
	2.38
	834.34m
	GB00BYW79Y38
	0.00
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.